NCT07096557View on ClinicalTrials.gov

The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 10, 2025

Study Completion Date

December 31, 2025

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Coenzyme Q10

Coenzyme Q10 100 mg capsule once daily for 3 months

Trial Locations (1)

Unknown

RECRUITING

The Pediatric Allergy, Immunology and Rheumatology Unit, Ain Shams University Hospitals., Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER